half life retatrutide Diagram showing the mechanism of action of Half-Life of Retatrutide: Pharmacokinetics, Dosing,

Find out in 60 seconds

Some analysts said the new results showed that both drugs which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December caused a higher rate of side effects than expected

Dehau, T., Cherlet, M., Croubels, S., Van Immerseel, F., & Goossens, E

[7] However, the use of GLP-1 agonists during pregnancy and lactation is less well understood, as these groups are typically excluded from clinical trials

Based on publicly available information, here's how Elevate Health's offerings generally position within the competitive landscape

Still, major trials on two GLP-1 drugs (tirzepatide and semaglutide) offer some information about the impact of these medications on muscle loss, according to a 2025 analysis in Obesity Reviews